John B. Hawken
Chief Executive Officer at Immutep SAS
Network origin in John B. Hawken first degree
Entity | Entity type | Industry | |
---|---|---|---|
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John B. Hawken via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member | |
ALLIANZ SE | Multi-Line Insurance | Corporate Officer/Principal | |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
IMMUTEP LIMITED | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
ELANIX BIOTECHNOLOGIES AG | Biotechnology | Director/Board Member | |
Allianz Versicherungs AG
Allianz Versicherungs AG Multi-Line InsuranceFinance Allianz Versicherungs-AG engages in the non-life insurance business. It provides general accident, liability, vehicle, legal expense, fire, credit and surety, as well as transport insurance services. The company is headquartered in Munich, Germany. | Multi-Line Insurance | Corporate Officer/Principal | |
Powderject Technologies BV | Director/Board Member | ||
University of Western Ontario | College/University | Masters Business Admin | |
Freie Universität Berlin | College/University | Masters Business Admin | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member | |
Sciences Po | College/University | Undergraduate Degree | |
IGREC SASU
IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | President | |
European Vaccine Manufacturers | President | ||
Pasteur Merieux MSD Ltd. | President | ||
caprotec bioanalytics GmbH
caprotec bioanalytics GmbH BiotechnologyHealth Technology caprotec bioanalytics GmbH commercializes Capture Compound Mass Spectrometry technology. It offers compound profiling services, supplies managing risk services, support the development of the health market and biomarker, rescues projects, selects and optimizes the development processes, and offers collaborations with other companies. The company was founded by Hubert Koester in 2007 and is headquartered in Berlin, Germany. | Biotechnology | Director of Finance/CFO | |
Texcell SA
Texcell SA Pharmaceuticals: MajorHealth Technology Texcell SA is a contract research organization that provides services for viral clearances, viral safety testing, and the manufacture of GMP cell banks to pharmaceutical companies and bioventures. The private company is based in France and has subsidiaries in various locations, including the United States. The French company has offices and laboratories in various locations around the world, including France, the United States, and Japan. The company's capabilities include in vivo, in vitro, toxicology, immunotoxicity, and immunogenicity testing, as well as CGMP cell banking and preparation of fully characterized virus stocks. Texcell has recently strengthened its activities to face the growing demand for tests related to COVID-19. The company is developing new innovative tests and new protocols in molecular biology and immunology. | Pharmaceuticals: Major | Director/Board Member | |
Pharma-Lizenz-Club Deutschland | Corporate Officer/Principal | ||
Centre Hospitalier Saint Joseph - Saint Luc | Chairman | ||
Noraker SARL
Noraker SARL Medical SpecialtiesHealth Technology Noraker SARL designs, produces and markets synthetic and absorbable biomaterial-based implantable medical devices. It offers dental surgery and orthopedic products. The firm's services include filling bone defects such as cyst and dental granuloma. The company was founded by Rachid Zenati in 2005 and is headquartered in Villeurbanne, France. | Medical Specialties | Chairman | |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
VALNEVA | Biotechnology | Director/Board Member | |
Hopital de Fourvière | Director/Board Member | ||
Institut de Pharmacie Industrielle de Lyon | College/University | Director/Board Member | |
Synthelis SAS
Synthelis SAS Pharmaceuticals: MajorHealth Technology Synthelis SAS manufactures membrane proteins. It specializes in the production, purification, and characterization of custom membrane proteins. The firm's services Membrane Protein (MP) expression, proteoliposomes, MP in detergents, feasibility study, and quality controls. Synthelis' technology enables the embedding of membrane proteins in liposomes directly during the translation step, allowing the production of active ready-to-use proteoliposomes. The company was founded by Bruno Tillier and Jean-Luc Lenormand in January 2011 and is headquartered in La Tronche, France. | Pharmaceuticals: Major | Director/Board Member | |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Biotechnology | Chief Executive Officer | |
Michel Greco SA
Michel Greco SA Miscellaneous Commercial ServicesCommercial Services Michel Greco SA provides postal, courier, and express services. The private company is based in Luxembourg, Luxembourg. The Luxembourger company was founded in 1987 by Michel Gréco. | Miscellaneous Commercial Services | Founder |
Statistics
International
France | 19 |
Germany | 10 |
United States | 5 |
Canada | 3 |
Switzerland | 3 |
Sectoral
Health Technology | 21 |
Consumer Services | 7 |
Commercial Services | 6 |
Finance | 3 |
Health Services | 2 |
Operational
Director/Board Member | 24 |
Corporate Officer/Principal | 10 |
Chairman | 5 |
President | 5 |
Director of Finance/CFO | 4 |
Most connected contacts
Insiders | |
---|---|
Michel Gréco | 28 |
Marc Voigt | 11 |
Frédéric Triebel | 6 |
Rafi Kazandjian | 2 |
- Stock Market
- Insiders
- John B. Hawken
- Company connections